Alembic Ltd.
| BSE: 506235 | Sector: Health care |
| NSE: ALEMBICLTD | ISIN Code: INE426A01027 |
| BSE 00:00 | 22 Sep | 115.95 |
1.25 (1.09%) |
OPEN
114.70 |
HIGH
118.65 |
LOW
114.45 |
| NSE 00:00 | 22 Sep | 115.95 |
1.30 (1.13%) |
OPEN
114.70 |
HIGH
118.70 |
LOW
114.55 |
| OPEN | 114.70 |
| PREVIOUS CLOSE | 114.70 |
| VOLUME | 131973 |
| 52-Week high | 143.30 |
| 52-Week low | 83.00 |
| P/E | 196.53 |
| Mkt Cap.(Rs cr) | 2,978 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Alembic Ltd. (ALEMBICLTD) - Company Information
Alembic Ltd
Alembic Ltd is one of the India's most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. They are the first pharmaceutical company in India to cross 100 years of operations. They are in the business of improving the quality of life and healthcare in over 75 countries around the world.The company is a ISO-9002 and ISO-14001 certified company with...> More
| COMPANY INFORMATION | |||||||
| Chairman : | Chirayu R Amin | ||||||
| Managing Director & CEO : | Malika C Amin | ||||||
| Independent Director : | C P Buch | ||||||
| Director : | Udit Amin | ||||||
| Director : | Abhijit Joshi | ||||||
| Independent Director : | Sameer Khera | ||||||
| Company Secretary : | Drigesh Mittal | ||||||
| Independent Director : | Rati Desai | ||||||
| Independent Director : | Mayank Amin | ||||||
| AUDITOR : | CNK & Associates LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs & Formln | ||||||
| HOUSE NAME : | Alembic Group | ||||||
| Registered office | |||||||
| Alembic Road, ,Vadodara,Gujarat-390003 | |||||||
| Ph : 91-0265-2280550 | |||||||
| WEBSITE : http://www.alembiclimited.com | |||||||
| E-mail : alembic.investors@alembic.co.in | |||||||
Quick Links for Alembic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
